Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Pulmonary Hypertension in Full Term Neonates
NCT07850934Recruiting
- Sponsor
- Ain Shams University
- Start
- Jul 2025
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Open-label trial of melatonin in pulmonary hypertension (PH) (2 arms), sponsored by Ain Shams University. Primary endpoint: Efficacy and Safety of Melatonin as Adjuvant Therapy at 72 hours. Started Jul 2025; status: recruiting.
02
Drugs
melatonin
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT07850934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07850934.